WE'RE ON A MISSION »
WE'VE A VISION »
WHO ARE WE
Scalene ANZ (SANZ) was conceptualized in 2020 as part of a global, dynamic organization called Organization de Scalene who is committed to bringing in cutting edge, novel, therapeutic medical devices for the betterment of humankind. Organization de Scalene has its presence in USA, Europe, South Africa, Malaysia & Sri Lanka. SANZ being the face of Organization de Scalene in Australia and New Zealand, are responsible for disseminating the research outcomes and implementing the commercial initiatives. This includes manufacturing and sales of medical devices, training of personnel, and post-sales services such as installation and maintenance. At the headquarters, Organization de Scalene group consists of 2 state of art research institutes. Scalene-Centre for Advanced Research and Development (S-CARD), the institute aims mainly at developing new treatments for human ailments & Scalene Energy Research Institute (SERI), developing innovative resource recovery projects.
Dr Rajah Vijay Kumar is the Global Chairman of Organization de Scalene. He is also the Chief Scientific officer of the research institutes. He has over 30 years of research, development, and global business experience. He founded Organization de Scalene in 1993, to promote Science and Technology in the areas of Healthcare, Energy, Food, Water, and Quality of Life. He is a pioneering researcher and an opinion leader in the field of Biophysics, Radiobiology, Nanotechnology, and Sustainable Energy. Specialized in Electronics and Bio-medical Engineering, he has worked for more than twenty years on regenerative tissue engineering and high-speed biological data acquisition, modeling, and simulation of the human cardiovascular system, artificial intelligence, and neural networks in medical diagnosis and engineering. Among over 43 patents held by him, Realistic Geometry Cartographic Imaging (RGCI) (finds applications from medical science to tsunami detection), & CYTOTRON® which is considered an important milestone in radiobiology and tissue engineering.
The Leadership
